Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
cancer
7
×
life sciences
national blog main
national top stories
boston blog main
new york blog main
san diego blog main
san diego top stories
san francisco blog main
startups
boston top stories
deals
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
clinical trials
eli lilly
fda
generic drugs
ipo
takeda pharmaceutical
venture capital
armo biosciences
avalon ventures
chemotherapy
What
drugs
7
×
bio
roundup
advance
biology
cytokine
enhanced
new
pharmaceutical
public
san
suite
synthetic
synthorx
adding
ago
ahead
aiming
answer
appetite
asco
away
bails
balance
biologic
black
brand
branded
bread
bridgebio
build
butter
buyout
cancer
capital
car
cash
choices
commissioner
company
Language
unset
Current search:
xconomy.com
×
drugs
×
cancer
×
@xconomy.com
4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Pelosi, Dems Unveil Price Plan: Are 25 Drugs Enough for Negotiation?
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs
@xconomy.com
6 years ago
Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs